Global Rapid Virus Diagnostic Test Market Size, Status and Forecast 2021-2027
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Rapid Virus Diagnostic Test Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
- 1.2.2 Influenza
- 1.2.3 RSV
- 1.2.4 Measles
- 1.2.5 Rubella
- 1.2.6 HIV/HPV
- 1.2.7 Others
- 1.3 Market by Application
- 1.3.1 Global Rapid Virus Diagnostic Test Market Share by Application: 2016 VS 2021 VS 2027
- 1.3.2 Hospitals
- 1.3.3 POCT
- 1.3.4 Others
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Rapid Virus Diagnostic Test Market Perspective (2016-2027)
- 2.2 Rapid Virus Diagnostic Test Growth Trends by Regions
- 2.2.1 Rapid Virus Diagnostic Test Market Size by Regions: 2016 VS 2021 VS 2027
- 2.2.2 Rapid Virus Diagnostic Test Historic Market Share by Regions (2016-2021)
- 2.2.3 Rapid Virus Diagnostic Test Forecasted Market Size by Regions (2022-2027)
- 2.3 Rapid Virus Diagnostic Test Industry Dynamic
- 2.3.1 Rapid Virus Diagnostic Test Market Trends
- 2.3.2 Rapid Virus Diagnostic Test Market Drivers
- 2.3.3 Rapid Virus Diagnostic Test Market Challenges
- 2.3.4 Rapid Virus Diagnostic Test Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Rapid Virus Diagnostic Test Players by Revenue
- 3.1.1 Global Top Rapid Virus Diagnostic Test Players by Revenue (2016-2021)
- 3.1.2 Global Rapid Virus Diagnostic Test Revenue Market Share by Players (2016-2021)
- 3.2 Global Rapid Virus Diagnostic Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Players Covered: Ranking by Rapid Virus Diagnostic Test Revenue
- 3.4 Global Rapid Virus Diagnostic Test Market Concentration Ratio
- 3.4.1 Global Rapid Virus Diagnostic Test Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Rapid Virus Diagnostic Test Revenue in 2020
- 3.5 Rapid Virus Diagnostic Test Key Players Head office and Area Served
- 3.6 Key Players Rapid Virus Diagnostic Test Product Solution and Service
- 3.7 Date of Enter into Rapid Virus Diagnostic Test Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Rapid Virus Diagnostic Test Breakdown Data by Type
- 4.1 Global Rapid Virus Diagnostic Test Historic Market Size by Type (2016-2021)
- 4.2 Global Rapid Virus Diagnostic Test Forecasted Market Size by Type (2022-2027)
5 Rapid Virus Diagnostic Test Breakdown Data by Application
- 5.1 Global Rapid Virus Diagnostic Test Historic Market Size by Application (2016-2021)
- 5.2 Global Rapid Virus Diagnostic Test Forecasted Market Size by Application (2022-2027)
6 North America
- 6.1 North America Rapid Virus Diagnostic Test Market Size (2016-2027)
- 6.2 North America Rapid Virus Diagnostic Test Market Size by Type
- 6.2.1 North America Rapid Virus Diagnostic Test Market Size by Type (2016-2021)
- 6.2.2 North America Rapid Virus Diagnostic Test Market Size by Type (2022-2027)
- 6.2.3 North America Rapid Virus Diagnostic Test Market Size by Type (2016-2027)
- 6.3 North America Rapid Virus Diagnostic Test Market Size by Application
- 6.3.1 North America Rapid Virus Diagnostic Test Market Size by Application (2016-2021)
- 6.3.2 North America Rapid Virus Diagnostic Test Market Size by Application (2022-2027)
- 6.3.3 North America Rapid Virus Diagnostic Test Market Size by Application (2016-2027)
- 6.4 North America Rapid Virus Diagnostic Test Market Size by Country
- 6.4.1 North America Rapid Virus Diagnostic Test Market Size by Country (2016-2021)
- 6.4.2 North America Rapid Virus Diagnostic Test Market Size by Country (2022-2027)
- 6.4.3 United States
- 6.4.4 Canada
7 Europe
- 7.1 Europe Rapid Virus Diagnostic Test Market Size (2016-2027)
- 7.2 Europe Rapid Virus Diagnostic Test Market Size by Type
- 7.2.1 Europe Rapid Virus Diagnostic Test Market Size by Type (2016-2021)
- 7.2.2 Europe Rapid Virus Diagnostic Test Market Size by Type (2022-2027)
- 7.2.3 Europe Rapid Virus Diagnostic Test Market Size by Type (2016-2027)
- 7.3 Europe Rapid Virus Diagnostic Test Market Size by Application
- 7.3.1 Europe Rapid Virus Diagnostic Test Market Size by Application (2016-2021)
- 7.3.2 Europe Rapid Virus Diagnostic Test Market Size by Application (2022-2027)
- 7.3.3 Europe Rapid Virus Diagnostic Test Market Size by Application (2016-2027)
- 7.4 Europe Rapid Virus Diagnostic Test Market Size by Country
- 7.4.1 Europe Rapid Virus Diagnostic Test Market Size by Country (2016-2021)
- 7.4.2 Europe Rapid Virus Diagnostic Test Market Size by Country (2022-2027)
- 7.4.3 Germany
- 7.4.4 France
- 7.4.5 U.K.
- 7.4.6 Italy
- 7.4.7 Russia
- 7.4.8 Nordic
8 Asia-Pacific
- 8.1 Asia-Pacific Rapid Virus Diagnostic Test Market Size (2016-2027)
- 8.2 Asia-Pacific Rapid Virus Diagnostic Test Market Size by Type
- 8.2.1 Asia-Pacific Rapid Virus Diagnostic Test Market Size by Type (2016-2021)
- 8.2.2 Asia-Pacific Rapid Virus Diagnostic Test Market Size by Type (2022-2027)
- 8.2.3 Asia-Pacific Rapid Virus Diagnostic Test Market Size by Type (2016-2027)
- 8.3 Asia-Pacific Rapid Virus Diagnostic Test Market Size by Application
- 8.3.1 Asia-Pacific Rapid Virus Diagnostic Test Market Size by Application (2016-2021)
- 8.3.2 Asia-Pacific Rapid Virus Diagnostic Test Market Size by Application (2022-2027)
- 8.3.3 Asia-Pacific Rapid Virus Diagnostic Test Market Size by Application (2016-2027)
- 8.4 Asia-Pacific Rapid Virus Diagnostic Test Market Size by Region
- 8.4.1 Asia-Pacific Rapid Virus Diagnostic Test Market Size by Region (2016-2021)
- 8.4.2 Asia-Pacific Rapid Virus Diagnostic Test Market Size by Region (2022-2027)
- 8.4.3 China
- 8.4.4 Japan
- 8.4.5 South Korea
- 8.4.6 Southeast Asia
- 8.4.7 India
- 8.4.8 Australia
9 Latin America
- 9.1 Latin America Rapid Virus Diagnostic Test Market Size (2016-2027)
- 9.2 Latin America Rapid Virus Diagnostic Test Market Size by Type
- 9.2.1 Latin America Rapid Virus Diagnostic Test Market Size by Type (2016-2021)
- 9.2.2 Latin America Rapid Virus Diagnostic Test Market Size by Type (2022-2027)
- 9.2.3 Latin America Rapid Virus Diagnostic Test Market Size by Type (2016-2027)
- 9.3 Latin America Rapid Virus Diagnostic Test Market Size by Application
- 9.3.1 Latin America Rapid Virus Diagnostic Test Market Size by Application (2016-2021)
- 9.3.2 Latin America Rapid Virus Diagnostic Test Market Size by Application (2022-2027)
- 9.3.3 Latin America Rapid Virus Diagnostic Test Market Size by Application (2016-2027)
- 9.4 Latin America Rapid Virus Diagnostic Test Market Size by Country
- 9.4.1 Latin America Rapid Virus Diagnostic Test Market Size by Country (2016-2021)
- 9.4.2 Latin America Rapid Virus Diagnostic Test Market Size by Country (2022-2027)
- 9.4.3 Mexico
- 9.4.4 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa Rapid Virus Diagnostic Test Market Size (2016-2027)
- 10.2 Middle East & Africa Rapid Virus Diagnostic Test Market Size by Type
- 10.2.1 Middle East & Africa Rapid Virus Diagnostic Test Market Size by Type (2016-2021)
- 10.2.2 Middle East & Africa Rapid Virus Diagnostic Test Market Size by Type (2022-2027)
- 10.2.3 Middle East & Africa Rapid Virus Diagnostic Test Market Size by Type (2016-2027)
- 10.3 Middle East & Africa Rapid Virus Diagnostic Test Market Size by Application
- 10.3.1 Middle East & Africa Rapid Virus Diagnostic Test Market Size by Application (2016-2021)
- 10.3.2 Middle East & Africa Rapid Virus Diagnostic Test Market Size by Application (2022-2027)
- 10.3.3 Middle East & Africa Rapid Virus Diagnostic Test Market Size by Application (2016-2027)
- 10.4 Middle East & Africa Rapid Virus Diagnostic Test Market Size by Country
- 10.4.1 Middle East & Africa Rapid Virus Diagnostic Test Market Size by Country (2016-2021)
- 10.4.2 Middle East & Africa Rapid Virus Diagnostic Test Market Size by Country (2022-2027)
- 10.4.3 Turkey
- 10.4.4 Saudi Arabia
- 10.4.5 UAE
11 Key Players Profiles
- 11.1 BD
- 11.1.1 BD Company Details
- 11.1.2 BD Business Overview
- 11.1.3 BD Rapid Virus Diagnostic Test Introduction
- 11.1.4 BD Revenue in Rapid Virus Diagnostic Test Business (2016-2021)
- 11.1.5 BD Recent Development
- 11.2 Abbot (Alere)
- 11.2.1 Abbot (Alere) Company Details
- 11.2.2 Abbot (Alere) Business Overview
- 11.2.3 Abbot (Alere) Rapid Virus Diagnostic Test Introduction
- 11.2.4 Abbot (Alere) Revenue in Rapid Virus Diagnostic Test Business (2016-2021)
- 11.2.5 Abbot (Alere) Recent Development
- 11.3 Quidel
- 11.3.1 Quidel Company Details
- 11.3.2 Quidel Business Overview
- 11.3.3 Quidel Rapid Virus Diagnostic Test Introduction
- 11.3.4 Quidel Revenue in Rapid Virus Diagnostic Test Business (2016-2021)
- 11.3.5 Quidel Recent Development
- 11.4 Roche
- 11.4.1 Roche Company Details
- 11.4.2 Roche Business Overview
- 11.4.3 Roche Rapid Virus Diagnostic Test Introduction
- 11.4.4 Roche Revenue in Rapid Virus Diagnostic Test Business (2016-2021)
- 11.4.5 Roche Recent Development
- 11.5 Thermo Fisher Scientific
- 11.5.1 Thermo Fisher Scientific Company Details
- 11.5.2 Thermo Fisher Scientific Business Overview
- 11.5.3 Thermo Fisher Scientific Rapid Virus Diagnostic Test Introduction
- 11.5.4 Thermo Fisher Scientific Revenue in Rapid Virus Diagnostic Test Business (2016-2021)
- 11.5.5 Thermo Fisher Scientific Recent Development
- 11.6 Meridian Bioscience
- 11.6.1 Meridian Bioscience Company Details
- 11.6.2 Meridian Bioscience Business Overview
- 11.6.3 Meridian Bioscience Rapid Virus Diagnostic Test Introduction
- 11.6.4 Meridian Bioscience Revenue in Rapid Virus Diagnostic Test Business (2016-2021)
- 11.6.5 Meridian Bioscience Recent Development
- 11.7 Analytik Jena
- 11.7.1 Analytik Jena Company Details
- 11.7.2 Analytik Jena Business Overview
- 11.7.3 Analytik Jena Rapid Virus Diagnostic Test Introduction
- 11.7.4 Analytik Jena Revenue in Rapid Virus Diagnostic Test Business (2016-2021)
- 11.7.5 Analytik Jena Recent Development
- 11.8 Princeton BioMeditech Corporation
- 11.8.1 Princeton BioMeditech Corporation Company Details
- 11.8.2 Princeton BioMeditech Corporation Business Overview
- 11.8.3 Princeton BioMeditech Corporation Rapid Virus Diagnostic Test Introduction
- 11.8.4 Princeton BioMeditech Corporation Revenue in Rapid Virus Diagnostic Test Business (2016-2021)
- 11.8.5 Princeton BioMeditech Corporation Recent Development
- 11.9 BioMerieux
- 11.9.1 BioMerieux Company Details
- 11.9.2 BioMerieux Business Overview
- 11.9.3 BioMerieux Rapid Virus Diagnostic Test Introduction
- 11.9.4 BioMerieux Revenue in Rapid Virus Diagnostic Test Business (2016-2021)
- 11.9.5 BioMerieux Recent Development
- 11.10 Sekisui Diagnostics
- 11.10.1 Sekisui Diagnostics Company Details
- 11.10.2 Sekisui Diagnostics Business Overview
- 11.10.3 Sekisui Diagnostics Rapid Virus Diagnostic Test Introduction
- 11.10.4 Sekisui Diagnostics Revenue in Rapid Virus Diagnostic Test Business (2016-2021)
- 11.10.5 Sekisui Diagnostics Recent Development
- 11.11 Response Biomedical
- 11.11.1 Response Biomedical Company Details
- 11.11.2 Response Biomedical Business Overview
- 11.11.3 Response Biomedical Rapid Virus Diagnostic Test Introduction
- 11.11.4 Response Biomedical Revenue in Rapid Virus Diagnostic Test Business (2016-2021)
- 11.11.5 Response Biomedical Recent Development
- 11.12 SA Scientific
- 11.12.1 SA Scientific Company Details
- 11.12.2 SA Scientific Business Overview
- 11.12.3 SA Scientific Rapid Virus Diagnostic Test Introduction
- 11.12.4 SA Scientific Revenue in Rapid Virus Diagnostic Test Business (2016-2021)
- 11.12.5 SA Scientific Recent Development
- 11.13 DiaSorin (Focus Diagnostics)
- 11.13.1 DiaSorin (Focus Diagnostics) Company Details
- 11.13.2 DiaSorin (Focus Diagnostics) Business Overview
- 11.13.3 DiaSorin (Focus Diagnostics) Rapid Virus Diagnostic Test Introduction
- 11.13.4 DiaSorin (Focus Diagnostics) Revenue in Rapid Virus Diagnostic Test Business (2016-2021)
- 11.13.5 DiaSorin (Focus Diagnostics) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
Global Rapid Virus Diagnostic Test Scope and Market Size
Rapid Virus Diagnostic Test market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Rapid Virus Diagnostic Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Influenza
RSV
Measles
Rubella
HIV/HPV
Others
Segment by Application
Hospitals
POCT
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
BD
Abbot (Alere)
Quidel
Roche
Thermo Fisher Scientific
Meridian Bioscience
Analytik Jena
Princeton BioMeditech Corporation
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
DiaSorin (Focus Diagnostics)